Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide

Modern Rheumatology

Volumn 24, Issue 3, 2014, Pages 529-531

  Momomura, Mei ^a   Miyamae, Takako ^a   Nozawa, Tomo ^a   Kikuchi, Masako ^a   Kizawa, Toshitaka ^a   Imagawa, Tomoyuki ^a   Drouot, Laurent ^b   Jouen, Fabienne ^b   Boyer, Olivier ^b   Yokota, Shumpei ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

Anti SRP antibody; Child; Cyclophosphamide; Necrotizing myopathy; Plasmapheresis

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; FRUCTOSE BISPHOSPHATE ALDOLASE; METHYLPREDNISOLONE; MYOGLOBIN; PREDNISOLONE; SIGNAL RECOGNITION PARTICLE; SIGNAL RECOGNITION PARTICLE 54; UNCLASSIFIED DRUG; AUTOANTIBODY; IMMUNOSUPPRESSIVE AGENT; SRP54 PROTEIN, HUMAN;

ADOLESCENT; ANTIBODY TITER; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BICEPS BRACHII MUSCLE; BLOOD EXAMINATION; CASE REPORT; DISEASE ACTIVITY; DYSPHAGIA; ELECTROMYOGRAPHY; FATIGUE; FEMALE; GLUTEUS MAXIMUS MUSCLE; HUMAN; IMMUNOASSAY; JAPANESE (PEOPLE); LEG MUSCLE; LIMB WEAKNESS; LYMPHADENITIS; MACROPHAGE; MAINTENANCE THERAPY; MOTOR UNIT POTENTIAL; MUSCLE BIOPSY; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ASSAY; SITTING; BLOOD; IMMUNOLOGY; MULTIMODALITY CANCER THERAPY; MUSCULAR DISEASES; TREATMENT OUTCOME;

ADOLESCENT; AUTOANTIBODIES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; MUSCULAR DISEASES; PLASMA EXCHANGE; SIGNAL RECOGNITION PARTICLE; TREATMENT OUTCOME;

EID: 84900392658     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2013.852852     Document Type: Article

References (13)

1. Brouwer R. Hengstman GJ. Vree Egberts W. Ehrfeld H. Bozic B Ghirardello A. Grøndal G. Hietarinta M. Isenberg D. Kalden JR Lundberg I. Moutsopoulos H. Roux-Lombard P. Vencovsky J Wikman A. Seelig HP. van Engelen BG. van Venrooij WJ. Autoantibody profi les in the sera of European patients with myositis. Ann Rheum Dis. 2001; 60: 116-123
2. K ao A H Lacomis D. Lucas M. Fertig N. Oddis C V. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic infl ammatory myopathy. Arthritis Rheum. 2004; 50 : 209-215
3. Rider L G Miller F W. Classifi cation and treatment of the juvenile idiopathic infl ammatory myopathies. Rheum Dis Clin North Am. 1997; 23: 619-655
4. Wedderburn LR. McHugh NJ. Chinoy H et al. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap. Rheumatology. 2007; 46: 1786-1791
5. Love LA. Leff R L Fraser D D et al. Anew approach to the classifi cation of idiopathic infl ammatory myopathy: Myositis-specifi c autoantibodies defi ne useful homogeneous patient groups. Medicine. 1990; 70 : 360-374
6. Targoff I N Johnson A E Miller F W. Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 1990; 33: 1361-1370
7. Kawabata T. Komaki H. Saito T. Saito Y. Nakagawa E. Sugai K Sasaki M. Hayashi YK. Nishino I. Momomura M. Kizawa T Imagawa T. Yokota S. Apediatric patient with myopathy associated with antibodies to a signal recognition particle. Brain Dev. 2012; 34 (10) : 877-80
8. Benveniste O. Drouot L. Jouen F. Charuel J. Bloch-Queyrat C Behin A. Amoura Z. Marie I. Guiguet M. Eymard B. Gilbert D Tron F. Herson S. Musset L. Boyer O. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum. 2011; 63 7 : 1961-1971
9. Arlet JB. Dimitri D. Pagnoux C. Boyer O. Maisonobe T Authier FJ. Bloch-Queyrat C. Goulvestre C. Heshmati F Atassi M. Guillevin L. Herson S. Benveniste O. Mouthon L. Marked effi cacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP). Neuromuscul Disord. 2006; 16 : 334-336
10. Gherardi R K. Pathogenic aspects of dermatomyositis polymyositis and overlap myositis. Presse Med. 2011; 40( 4 Pt 2): E209-e218
11. Brewer E J J r Giannini E H Rossen R D et al. Plasma exchange therapy of a childhood onset dermatomyositis patient. Arthritis Rheum. 1980; 23: 509-513
12. Anderson L. Ziter F A. Plasmapheresis via central catheter in Dermatomyositis: New method for selected pediatric patients. J Pediatr. 1981; 98: 240-241
13. Miller FW. Leitman SF. Cronin ME. Hicks JE. Leff RL. Wesley R Fraser DD. Dalakas M. Plotz PH. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med. 1992; 326 (21): 1380-1384